Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryBlood coagulation and the risk of atherothrombosis: a complex relationshipRanolazine: A Contemporary ReviewCoronary artery revascularization in patients with diabetes mellitusVascular disease in diabetic women: Why do they miss the female protection?Renal autoregulation in health and diseaseAdvanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36.Quantitative analysis of peripheral tissue perfusion using spatiotemporal molecular dynamics.Vinpocetine attenuates neointimal hyperplasia in diabetic rat carotid arteries after balloon injury.Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes.Predictors of coronary heart disease in Japanese patients with type 2 diabetes: Screening for coronary artery stenosis using multidetector computed tomography.Intracellular Ca2+ regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia.Associations among metabolic syndrome, ischemia, inflammatory, oxidatives, and lipids biomarkersThe cross-sectional associations between sense of coherence and diabetic microvascular complications, glycaemic control, and patients' conceptions of type 1 diabetesMRI plaque imaging reveals high-risk carotid plaques especially in diabetic patients irrespective of the degree of stenosisMRI plaque imaging and its role in population-based studiesAssociation of cardiac and vascular changes with ambient PM2.5 in diabetic individualsInhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic ratsEverolimus-eluting stents improve vascular response in a diabetic animal model.Diabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Shen-Fu injection preconditioning inhibits myocardial ischemia-reperfusion injury in diabetic rats: activation of eNOS via the PI3K/Akt pathwayMean platelet volume and platelet counts in type 2 diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria.Oxidative status imbalance in patients with metabolic syndrome: role of the myeloperoxidase/hydrogen peroxide axis.Prognostic value of admission heart rate in patients with ST-segment elevation myocardial infarction: role of type 2 diabetes mellitus.Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention.Second- versus first-generation drug-eluting stents for diabetic patients: a meta-analysis.Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.The interventional therapy for diabetic peripheral artery disease.Kolaviron, a Garcinia biflavonoid complex ameliorates hyperglycemia-mediated hepatic injury in rats via suppression of inflammatory responses.Comparison of the hospital arrival time and differences in pain quality between diabetic and non-diabetic STEMI patients.Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats.Peripheral arterial disease, prevalence and cumulative risk factor profile analysis.Pharmacogenomics of cardiovascular complications in diabetes and obesity.Retinal Vessel Tortuosity and Its Relation to Traditional and Novel Vascular Risk Markers in Persons with Diabetes.High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study.Enhanced cerebral but not peripheral angiogenesis in the Goto-Kakizaki model of type 2 diabetes involves VEGF and peroxynitrite signaling.Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complexMechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aortaSerine Protease Activation Essential for Endothelial-Mesenchymal Transition in Vascular Calcification.Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.
P2860
Q22241786-D74566E2-6CDD-44EB-9722-8F27A57F924DQ24808644-88041EB8-0FFA-4912-BAFC-68A8539E560CQ26765421-FFB3BA32-6404-4C27-89CF-3ED5A05D4084Q26824002-CDFEB2CD-D2C5-4080-8A81-56874F3D3CAFQ27011447-A8ADD16D-64C1-49A4-9F9F-870EB103058FQ28082365-0DB2708F-229D-4F08-AEE7-2EE202597A27Q30518002-E2328A02-B7FB-46DF-A849-7709C614622DQ33402912-9D8237B3-4DBB-4580-82A6-6B856823849FQ33599923-A2F155F5-45E2-4184-82FD-133AE1EB846BQ33602340-9B35C4C8-B7A8-4BC7-BD8C-CD6B80CFBAF8Q33609507-3D724517-E161-4250-869F-0909B59D38E5Q33691901-6446D8B8-7F9D-423A-B35A-8424A2A9C6FCQ33736191-8AFD6F69-C906-41BE-AF17-5048B014E2BFQ33756811-E83E00D9-58E5-4DB3-B9C5-46149DBF6E06Q33759007-649089B8-7911-4927-8EC6-8BA03BE9E1EEQ33759027-7907CCEE-A3BD-4B61-A70F-51B6EC33F4EEQ33961204-B85BDD6E-9EC0-4353-92D2-D32D08888ECCQ34067524-7F25F343-72BF-4B23-BE0F-BA12089897AEQ34076128-EB68A9A8-1C43-4251-97A8-EDFE85F08600Q34350546-EE7B0BD8-8A58-47C2-A339-84DFF5DC39E6Q34382922-60B232D1-5C8B-437A-9A9C-6ABA54E64AB9Q34431756-0E1218A2-8483-4F4E-BE9E-558D1EAF7CDFQ34438220-79567FA0-E5C3-4232-A65D-3B4520ECE4C6Q34478486-532BE710-03C1-4FE3-8E32-91175EF66002Q34620441-56C65CC4-4FBB-45E0-BD2B-4ADAF6BED16AQ34662245-48CB4AA0-74A4-47F6-BD1C-CCAF2CDDD85BQ34793647-12BCFBB8-4AAC-449F-B034-D9DC676BBC46Q34956122-71ECBC39-E27B-4DA2-B3F9-489CC60E1B61Q35073701-256BC826-A0D0-42C7-BD63-6531EE95FF6BQ35131648-87FBBF86-71BD-47DE-82DA-F2D42594AD31Q35314875-F09AF525-004B-462D-9CEA-AD05D7A4E93FQ35621575-33B49058-EB89-4FB2-80F0-F5ECA7C5C231Q35647167-7F4FA9EF-71EF-40D4-A406-DB4419F9DCBFQ35666978-D8A8CFE5-4523-4470-A634-6A0511BA67B9Q35736714-7EA7DDE9-E076-4529-B122-789FDD60CBCFQ35976637-762CBE5F-53AC-4987-ADDE-31AB1D634133Q36047487-7753134E-61ED-4619-9616-6D24EB2C9F58Q36054473-43819D10-1D92-4BCF-BF8A-052AA27EF510Q36144932-F50D60AA-AF2C-4F39-AB1A-D8F3F67D1C60Q36154232-BA27912C-1DE8-489D-9012-002713206663
P2860
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Diabetes and vascular disease: ...... and medical therapy: Part II.
@ast
Diabetes and vascular disease: ...... and medical therapy: Part II.
@en
type
label
Diabetes and vascular disease: ...... and medical therapy: Part II.
@ast
Diabetes and vascular disease: ...... and medical therapy: Part II.
@en
prefLabel
Diabetes and vascular disease: ...... and medical therapy: Part II.
@ast
Diabetes and vascular disease: ...... and medical therapy: Part II.
@en
P2093
P1433
P1476
Diabetes and vascular disease: ...... and medical therapy: Part II.
@en
P2093
Francesco Cosentino
Joshua A Beckman
Mark A Creager
P304
P356
10.1161/01.CIR.0000089189.70578.E2
P407
P577
2003-09-01T00:00:00Z